Literature DB >> 9430729

The XRCC4 gene product is a target for and interacts with the DNA-dependent protein kinase.

R Leber1, T W Wise, R Mizuta, K Meek.   

Abstract

The gene product of XRCC4 has been implicated in both V(D)J recombination and the more general process of double strand break repair (DSBR). To date its role in these processes is unknown. Here, we describe biochemical characteristics of the murine XRCC4 protein. XRCC4 expressed in insect cells exists primarily as a disulfide-linked homodimer, although it can also form large multimers. Recombinant XRCC4 is phosphorylated during expression in insect cells. XRCC4 phosphorylation in Sf9 cells occurs on serine, threonine, and tyrosine residues. We also investigated whether XRCC4 interacts with the other factor known to be requisite for both V(D)J recombination and DSBR, the DNA-dependent protein kinase. We report that XRCC4 is an efficient in vitro substrate of DNA-PK and another unidentified serine/ threonine protein kinase(s). Both DNA-PK dependent and independent phosphorylation of XRCC4 in vitro occurs only on serine and threonine residues within the COOH-terminal 130 amino acids, a region of the molecule that is not absolutely required for XRCC4's DSBR function. Finally, recombinant XRCC4 facilitates Ku binding to DNA, promoting assembly of DNA-PK and complexing with DNA-PK bound to DNA. These data are consistent with the hypothesis that XRCC4 functions as an alignment factor in the DNA-PK complex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9430729     DOI: 10.1074/jbc.273.3.1794

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  56 in total

1.  Ku recruits the XRCC4-ligase IV complex to DNA ends.

Authors:  S A Nick McElhinny; C M Snowden; J McCarville; D A Ramsden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Reconstitution of the mammalian DNA double-strand break end-joining reaction reveals a requirement for an Mre11/Rad50/NBS1-containing fraction.

Authors:  Juren Huang; William S Dynan
Journal:  Nucleic Acids Res       Date:  2002-02-01       Impact factor: 16.971

3.  A single amino acid substitution in DNA-PKcs explains the novel phenotype of the CHO mutant, XR-C2.

Authors:  Timothy Woods; Wei Wang; Erin Convery; Abdellatif Errami; Malgorzata Z Zdzienicka; Katheryn Meek
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

4.  Synapsis of DNA ends by DNA-dependent protein kinase.

Authors:  Lisa G DeFazio; Rachel M Stansel; Jack D Griffith; Gilbert Chu
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

5.  An xrcc4 defect or Wortmannin stimulates homologous recombination specifically induced by double-strand breaks in mammalian cells.

Authors:  Fabien Delacôte; Mingguang Han; Thomas D Stamato; Maria Jasin; Bernard S Lopez
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

6.  XLF regulates filament architecture of the XRCC4·ligase IV complex.

Authors:  Michal Hammel; Yaping Yu; Shujuan Fang; Susan P Lees-Miller; John A Tainer
Journal:  Structure       Date:  2010-11-10       Impact factor: 5.006

Review 7.  DNA-PK: a dynamic enzyme in a versatile DSB repair pathway.

Authors:  Anthony J Davis; Benjamin P C Chen; David J Chen
Journal:  DNA Repair (Amst)       Date:  2014-03-27

8.  DNA binding of Xrcc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity.

Authors:  M Modesti; J E Hesse; M Gellert
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

9.  DNA end-joining catalyzed by human cell-free extracts.

Authors:  P Baumann; S C West
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV.

Authors:  Christine Anne Koch; Roger Agyei; Sarah Galicia; Pavel Metalnikov; Paul O'Donnell; Andrei Starostine; Michael Weinfeld; Daniel Durocher
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.